Physics of Cancer
Physics of Cancer-- with an emphasis in brain cancer, modeling of tumors, imaging of brain tumors, and problems in imaging segmentation. This Pearltree isn't concerned with the use of physics in therapies (treatment of cancer). Why use theoretical physics in cancer studies? Physicist are good are working with subtle and complex problems, and have been quite successful in identifying key parameteres and underlying principles that lead to deep understading of different complex systems.These habilities and theoretical knowledge are now being applied to the understanding of cancer. Oct 8
At Johns Hopkins, the brain tumor team will perform a variety of examinations to diagnosis a brain tumor. Magnetic resonance imaging (MRI) and computed tomography (CT or CAT scan) are the most common types of tests used to diagnose brain tumors.
Brain tumor specimens taken from neurosurgery cases at the University of California, San Francisco (UCSF) Medical Center has given scientists a new window on the transformation that occurs as healthy brain cells begin to form tumors. The work may help identify new drugs to target oligodendroglioma, a common type of brain tumor, at its earliest stage, when it is generally most treatable.
A physicist working on cancer? Make that an astrophysicist. "I started out doing measurements on nuclear reactions that occur in the center of stars," says Ann Schmiedekamp, associate professor of physics at Penn State's Ogontz campus. That was 20 years ago. In the course of raising four children and building an academic career alongside her husband—also trained in physics—Schmiedekamp has found it useful to be able to adapt.
Fisica y Cancer (Spanish)
Sunday, March 17 1:30 p.m. - 5:30 p.m.
This prototype proton CT scanner was developed in the SCIPP laboratories by a team of physicists led by Hartmut Sadrozinski. (PhysOrg.com) -- Physicists at the University of California, Santa Cruz, are working with medical researchers at Loma Linda University Medical Center to develop a new imaging technology to guide proton therapy for cancer treatment.
We are happy to announce the winners of the Best Poster Prize Competition: 1. Prize (IPad 32 G)
These fluorescent images show how branching morphogenesis in breast tissue is determined by tubule geometry and is consistent with the idea that branching takes place where concentrations of branching inhibitors are lowest. (A) shows curved tubules, (B) bifurcated tubules and (C) fractal trees. Images (D) through (F) show corresponding branching inhibitor concentrations.
Apr. 23, 2009 — As early as one week after beginning treatment for brain tumors, a new imaging analysis method was able to predict which patients would live longer, researchers from the University of Michigan Comprehensive Cancer Center have found.
Main Category: Cancer / Oncology Also Included In: Neurology / Neuroscience Article Date: 10 Jan 2011 - 4:00 PDT Current ratings for: Researchers Pinpoint Origin Of Deadly Brain Tumor - Oligodendrogliomas Scientists have identified the type of cell that is at the origin of brain tumors known as oligodendrogliomas, which are a type of glioma - a category that defines the most common type of malignant brain tumor .
Mar 26, 2007 - Mar 30, 2007 West Park Conference Centre, Dundee Organisers
With rendition switcher Question: What do you hope to accomplish by applying physics to cancer research? Paul Davies: A couple of years ago I had a call from the deputy director at the National Cancer Institute, Anna Barker, with an amazing proposal.
October 26, 2009 Print version The Johns Hopkins Engineering in Oncology Center at INBT will be headed by Denis Wirtz, left. Gregg Semenza will serve as associate director. Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded a $14.8 million grant from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings that drive the growth and spread of cancer. The new Johns Hopkins Engineering in Oncology Center at INBT includes 11 Johns Hopkins faculty members affiliated with the INBT and four investigators from partner universities.
Research Overview As a group of genetic diseases, cancer presents some of the most challenging problems for basic scientists, clinical investigators, and practitioners. In order to design treatments that are capable of specifically targeting the invasive cancer cells that drive malignant tumor growth, it is necessary to understand the mechanisms by which these cells initiate angiogenesis, enhance their motility, relax adhesive cellular bonds and penetrate normal tissue.